Acute and chronic onset of bronchiolitis obliterans syndrome (BOS): are they different entities?

BACKGROUND Bronchiolitis obliterans syndrome (BOS), defined as an irreversible, staged decline in forced expiratory volume in 1 second (FEV(1)), is an established marker of obliterative bronchiolitis. Potential causes of BOS include sub-clinical chronic rejection and/or exaggerated healing response following acute injury. BOS may thus result from two or more distinct processes, both acute and chronic. METHODS A total of 5,916 measurements of FEV(1) from 204 lung transplant recipients surviving at least 6 months after transplantation were analyzed. Follow-up ranged from 6 months to 13 years. By adjusting for the acute effects of rejection, pulmonary infection and measurement variation on FEV(1) trace, patients either had a linear decline characterized by a single acute drop in FEV(1) of >15% at BOS onset, or a chronic linear decline in FEV(1). The fraction having acute onset was estimated. Acute events occurring within the first 6 months were assessed as risk factors for acute onset BOS. RESULTS Of the 204 patients, 8% died before BOS onset and 18% were BOS-free at analysis. For 18% of patients, BOS onset followed a chronic linear decline in FEV(1) of 3.7% per year, with a median time of BOS onset >99 months. For 56% of patients, BOS onset followed an acute drop in FEV(1) of median 33.8% (95% CI 19.1% to 39.7%), with median onset time of 52 months. During the first 6 months, acute rejection was significantly and independently associated with acute onset of BOS (relative risk = 1.15 per episode, 95% CI [1.03 to 1.29], p = 0.01), whereas pulmonary infection and cytomegalovirus (CMV) infection were not. Acute BOS onset followed a documented acute event in the previous 6 months in 38 of 114 (33%) of cases. CONCLUSIONS BOS likely reflects more than one process. Compared with those who had a slow linear decline in lung function, acute BOS onset was associated with acute rejection in the first 6 months, was often triggered by an acute event and had poor prognosis, with obliterative bronchiolitis (OB) the main cause of death.

[1]  J. Theodore,et al.  Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[2]  B. Griffith,et al.  Does histologic acute rejection in lung allografts predict the development of bronchiolitis obliterans? , 1991, Transplantation.

[3]  G. Berry,et al.  Risk factors for the development of obliterative bronchiolitis after lung transplantation. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[4]  S. Yousem,et al.  Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation. , 1984, Chest.

[5]  D Heng,et al.  Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[6]  L. Sharples,et al.  Immunologic mechanisms underlying bronchiolitis obliterans , 2000 .

[7]  P. Hasleton,et al.  Transforming growth factor beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[8]  G. Patterson,et al.  A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. , 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[9]  P. Corris,et al.  Tests of airway function in detecting and monitoring treatment of obliterative bronchiolitis after lung transplantation. , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[10]  R. Bolman,et al.  ARE MULTIPLE IMMUNOPATHOGENETIC EVENTS OCCURRING DURING THE DEVELOPMENT OF OBLITERATIVE BRONCHIOLITIS AND ACUTE REJECTION? , 1993, Transplantation.

[11]  B. Griffith,et al.  Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management. , 1995, The Journal of thoracic and cardiovascular surgery.